USPTO 2015–2025 USPTO PatentsView US Corporation

Nuvectra Corporation

USPTO PatentsView assignee record — 76 granted patents across 21 technology areas, active 2016–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

76
Total patents granted
21
CPC technology areas
21.9
Avg claims per patent
-97%
5-year filing velocity

The verdict

Nuvectra holds 76 US patents across 21 technology areas — rank #4,636 of 50,000 tracked assignees.

#4,636
of 50,000 US assignees by volume
Top 26%
by Innovation Score (44.4/100)
21.9
avg claims per patent
-97%
filing velocity, last 5 yrs

Portfolio overview

NUVECTRA CORPORATION has been granted 76 US utility patents between 2016 and 2020, placing NUVECTRA CORPORATION at rank #4,636 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.9 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, NUVECTRA CORPORATION is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 74 in the 2015–2019 window — a -97% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. NUVECTRA CORPORATION's 21.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark NUVECTRA CORPORATION against peers pursuing similar technology classes.

How does NUVECTRA compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows NUVECTRA holds 76 patents — placing it at rank #4,636 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

NUVECTRA's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

0510152025 20162017201820192020 2
USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
NUVECTRA CORPORATION patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 18 23.7%
2017 20 26.3%
2018 23 30.3%
2019 13 17.1%
2020 2 2.6%

Which technologies does NUVECTRA CORPORATION patent most?

Top 15 of 21 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#4,636

Across all tracked assignees

Innovation Score

44.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does NUVECTRA CORPORATION hold?
NUVECTRA CORPORATION holds 76 US granted patents filed between 2016 and 2020, spanning 21 technology areas.
What is NUVECTRA CORPORATION's Innovation Score?
NUVECTRA CORPORATION has an Innovation Score of 44.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does NUVECTRA CORPORATION focus on?
NUVECTRA CORPORATION's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 73 patents. The company has filed patents in 21 CPC subclasses total.
Is NUVECTRA CORPORATION's patent filing rate increasing or decreasing?
NUVECTRA CORPORATION's recent filing velocity is -97% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for NUVECTRA CORPORATION's patents?
NUVECTRA CORPORATION's patents average 21.9 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the NUVECTRA CORPORATION patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Nuvectra's 76 grants land it in the top 26% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Nuvectra ranks #4,636 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N — see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov